They mimic a natural gut hormone called GLP-1, which is released after eating and helps coordinate metabolism in several ways: they slow how quickly food leaves the stomach, increase feelings of fullness in the brain, reduce appetite, and help the pancreas release insulin when blood sugar rises while also lowering glucagon, a hormone that tells the liver to release stored sugar
For patients on concurrent sulfonylureas or insulin, consider reducing those doses by 20-50% at switch to reduce hypoglycemia risk, then readjust based on glucose data over the following 2-4 weeks
Rapiblyk is intended for use in the emergency and critical care departments, as well as in the operating and intensive care settings
Outcomes renali nei pazienti diabetici trattati con GLP-1RA: revisione della letteratura Numerosi studi pubblicati in letteratura hanno indagato gli effetti nefroprotettivi dei GLP-1RA nei pazienti diabetici (Tabella III)
Statins, vascular calcification and vitamin K-dependent proteins: is there a relation